Ivy Sports Medicine v. Burwell, et al.: FDA May Not “Short-Circuit” the Process For Reclassifying Medical Devices, Rules Federal Appeals Court Read more
Shire Pharmaceuticals Settles for $56.5 Million to Resolve False Claims Act Allegations Over ADHD Drugs Read more